AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Holders of 5% or more of ABCL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of AbCellera Biologics Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of AbCellera Biologics Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on AbCellera Biologics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 9, 202410:20 AM ET | Baillie Gifford & Co | 13G/A | 4.40%12.9M shares | –Below 5% | Sep 30, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell AbCellera Biologics Inc. shares.
No Form 144 notices for AbCellera Biologics Inc. are on file.